Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.
Related Posts
Nokia Says German Court Ruled in its Favor Over Amazon Patent Dispute
Nokia had claimed the unauthorized use of its video-related technologies in streaming services and devices by Amazon.
TotalEnergies Expects Flat Hydrocarbon Output
TotalEnergies said it expected third-quarter hydrocarbon production to remain largely unchanged from the second quarter, as it reported a fall in net profit for the […]
Transportation Department Blesses Alaska Air-Hawaiian Merger, With Strings
The carriers secured clearance from the Transportation Department to proceed with their merger, conditioned on the airlines maintaining service on crucial routes, preserving the value […]